Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-25-005831
Filing Date
2025-04-29
Accepted
2025-04-29 16:07:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A chrs-20250429xdefa14a.htm DEFA14A 19271
2 GRAPHIC chrs-20250429xdefa14a_bg001.jpg GRAPHIC 148210
3 GRAPHIC chrs-20250429xdefa14a_bg002.jpg GRAPHIC 112855
  Complete submission text file 0001558370-25-005831.txt   380378
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 25887222
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)